ProShare Advisors
TVGN icon

ProShare Advisors’s Tevogen Inc TVGN Stock Holding History

ProShare Advisors’s Portfolio TVGN Stock Details TVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-242
Closed -$9.51K – 2101
2025
Q3 		$9.51K Sell
242
-12
-5% -$590 ﹤0.01% 2005
2025
Q2 		$15.8K Sell
254
-5
-2% -$285 ﹤0.01% 2074
2025
Q1 		$14K Sell
259
-35
-12% -$2.3K ﹤0.01% 2055
2024
Q4 		$15.1K Buy
+294
New +$19.2K ﹤0.01% 2259

Other funds holding TVGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

ProShare Advisors's TVGN Position: Q4 2025 in Review

ProShare Advisors sold out of Tevogen Inc (TVGN) in Q4 2025, closing a stake of 242 shares — an estimated $9.51K sold.

ProShare Advisors first reported a position in TVGN in Q4 2024 and held it in 4 quarters. The position peaked at $15.8K in Q2 2025. 51 funds tracked by Wall St. Rank hold TVGN as of Q4 2025.

  • ProShare Advisors reported no remaining Tevogen Inc position as of Q4 2025 after selling out during the quarter.
  • ProShare Advisors sold 242 Tevogen Inc shares in Q4 2025, an estimated $9.51K.
  • ProShare Advisors first reported a position in Tevogen Inc in Q4 2024 and held it in 4 quarters.
  • ProShare Advisors's Tevogen Inc position peaked at $15.8K in Q2 2025.
  • 51 funds tracked by Wall St. Rank held Tevogen Inc as of Q4 2025.

Based on ProShare Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.